<span style="color: #222222;">Drugs Controller General of India, DCGI has allowed Dr. Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) to conduct phase 2 and 3 clinical human trials of Sputnik 5 COVID vaccine in the country.&nbsp;</span><br />” <br />” <span style="color: #222222;">Sputnik 5 Vaccine has been developed in Russia where it has also undergone phase 1 and 2 clinical trials. The clinical trial in India will be a multi-center and randomised controlled study which will primarily focus on safety and immunogenicity study.&nbsp;</span><br />” <br />” <span style="color: #222222;">Earlier last month, Dr. Reddy's and RDIF entered into partnership to conduct clinical trials of Sputnik 5 vaccine and its distribution in the country.</span><br />” <span style="color: #222222;">The vaccine is currently undergoing phase 3 clinical trials in Russia along with simultaneous trails in UAE.</span><br />” ”<table cellspacing="0" cellpadding="0" style="border-left: 1px solid black; border-top: 1px solid black;"> ”<tbody>”<tr> ”<td valign="top" style="border-right: 1px solid black; border-bottom: 1px solid black;"></td> ”<td style="border-right: 1px solid black; border-bottom: 1px solid black;"></td> </tr> </tbody></table><br />